|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|
| ASSETS | |||
| Cash and due from banks | |||
| Restricted cash | |||
| Interest-bearing due from banks | |||
| Cash and cash equivalents | |||
| Securities Purchased under Agreements to Resell | |||
| Securities available-for-sale, at fair value | |||
| Securities held-to-maturity (fair value of $2.4 billion and $2.6 billion, net of allowance for credit losses of $1.7 million and $1.7 million at Dec. 31, 2025 and 2024, respectively) | |||
| Consumer loans held-for-sale | |||
| Federal funds sold, securities purchased under resale agreements, and interest earning deposits with banks | |||
| Total cash, cash equivalents, and restricted cash | |||
| Investment securities held to maturity, net | |||
| Investment securities available for sale | |||
| Loans held for sale (includes $42 million at fair value as of Jun 30, 2026 and none at fair value as of Dec. 31, 2025) | |||
| Financing Receivable, before Allowance for Credit Loss | |||
| Financing Receivable, Allowance for Credit Losses | |||
| Financing Receivable, after Allowance for Credit Loss | |||
| Premises and equipment, net | |||
| Equity method investment | |||
| Accrued interest receivable | |||
| Loans, net of deferred fees and costs | |||
| Allowance for loan losses | |||
| Loans, net | |||
| Premises, equipment, and software, net | |||
| Cash surrender value of bank-owned life insurance | |||
| Goodwill | |||
| Core deposits and other intangible assets | |||
| Other real estate owned | |||
| Core deposits and other intangible assets, net | |||
| Other assets | |||
| Total assets | |||
| LIABILITIES AND EQUITY | |||
| Liabilities | |||
| Deposits: | |||
| Non-interest-bearing | |||
| Interest-bearing | |||
| Savings and money market accounts | |||
| Time Deposits | |||
| Total deposits | |||
| Securities sold under agreements to repurchase | |||
| Federal Home Loan Bank advances | |||
| Subordinated debt and other borrowings | |||
| Accrued interest payable | |||
| Non-interest-bearing deposits | |||
| Interest-bearing deposits | |||
| Total deposits | |||
| Federal funds purchased and securities sold under repurchase agreements | |||
| FHLB advances and other borrowings | |||
| Other liabilities | |||
| Total liabilities | |||
| Equity | |||
| Shareholders' equity: | |||
| Preferred stock, no par value; 10.0 million shares authorized; 225,000 shares non-cumulative perpetual preferred stock, Series B, liquidation preference $225.0 million, issued and outstanding at Dec. 31, 2025 and 2024, respectively | |||
| Common stock, par value $1.00; 180.0 million shares authorized; 77.7 million and 77.2 million shares issued and outstanding at Dec. 31, 2025 and 2024, respectively | |||
| Preferred stock — no par value per share, liquidation preference 225 million non-cumulative perpetual preferred stock, Authorized — 110 million shares at Jun 30, 2026 and 10 million shares at Dec 31, 2025, Issued and outstanding — 22 million shares at Jun 30, 2026 and 225,000 shares at Dec 31, 2025 | |||
| Common stock — $1.00 par value, Authorized — 360 million shares at Jun 30, 2026 and 180 million shares at Dec. 31, 2025, Issued and outstanding — 151 million shares at June 30, 2025 and 78 million at Dec. 31, 2025 | |||
| Additional paid-in capital | |||
| Accumulated other comprehensive income (loss), net | |||
| Retained earnings | |||
| Total equity | |||
| Total liabilities and equity |
Loading...
